CONSOLIDATED BALANCE SHEETS (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current Assets
Cash	€ 297	€ 286
Receivables	3,712	43
Prepaid expenses	57	52
Total current assets	4,066	381
Property and equipment, net of accumulated depreciation of E281 and E261 at December 31, 2013 and 2012, respectively	117	28
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	13,120	9,346
Current Liabilities
Accounts payable	858	1,325
Acquisition-related contingent consideration	236	0
Convertible notes payable to related Parties	39,123	34,723
Total current liabilities	40,217	36,048
Acquisition-related contingent consideration	0	6,533
Total liabilities	40,217	42,581
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; 850,000,000 shares authorized; issued 298,418,813 at December 31, 2013 and 295,318,813 at December 31, 2012	2,491	2,468
Preferred stock, U.S. $.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,876	33,783
Deficit accumulated during the development stage	(64,165)	(70,168)
Accumulated other comprehensive income	701	682
Total shareholders' equity (deficit)	(27,097)	(33,235)
Total liabilities and shareholders' equity (deficit)	€ 13,120	€ 9,346